Source: Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Tracy Hussell, Sylvia Lui, Christopher Jagger, David Morgan, Oliver Brand. The consequence of matrix dysfunction on lung immunity and the microbiome in COPD. Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018

Member's Comments

No comment yet.

Related content which might interest you: The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015 The consequences of microbiome and pathogen dynamics for chronic lung diseases Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation Year: 2012 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Influence of bacteria from the COPD lung microbiome on cigarette smoke-induced pro-inflammatory responses of three-dimensional lung epithelial cell cultures Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 The pulmonary microbiome and immunological activity in IPF patients. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 The nature of inflammation and tissue damage in COPD Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD Year: 2004 Decreasing of lung function in patients with chronically obstructive lung diseases as effect of damage of bronchial mucosa cilia Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003 The innate immune function of airway epithelial cells in inflammatory lung disease Source: Eur Respir J 2015; 45: 1150-1162 Year: 2015 Why does chronic bronchitis and lung infection accelerate lung function decline Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Is lung emphysema in COPD patients reflected by central airways inflammation? Source: Eur Respir J 2003; 22: Suppl. 45, 207s Year: 2003 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 The impact of bacterial colonisation on airway inflammation in stable COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019 Year: 2021 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020